Literature DB >> 17382108

Follow-up study of a randomized controlled trial of postnatal dexamethasone therapy in very low birth weight infants: effects on pulmonary outcomes at age 8 to 11 years.

Patricia A Nixon1, Lisa K Washburn, Michael S Schechter, T Michael O'Shea.   

Abstract

OBJECTIVE: To determine whether postnatal dexamethasone (DEX) exposure affects pulmonary outcomes at school age in children born with very low birth weight (VLBW). STUDY
DESIGN: Follow-up study of 68 VLBW children who participated in a randomized controlled trial of postnatal DEX. Pulmonary function was assessed by spirometry. Current asthma status was obtained from a parent.
RESULTS: Sixty-eight percent of the placebo group had below-normal forced expiratory volume in 1 second (FEV1), compared with 40% of the DEX group (chi2 = 4.84; P = .03), with trends for lower forced vital capacity (FVC) and FEV1 values in the placebo group. Fifty percent of the placebo group and 34% of DEX group had below normal FEV1/FVC (chi2 =1.59; P =.21). Parent-reported prevalence of asthma did not differ between groups. Logistic regression analysis suggested that the positive effects of DEX on pulmonary function at follow-up were mediated in part by shortened exposure to mechanical ventilation.
CONCLUSIONS: Postnatal DEX exposure was associated with higher expiratory flow with no adverse effects on pulmonary outcomes at school age. The prevalences of asthma and impaired pulmonary function underscore the influence of neonatal illness on health at school age, and stress the importance of repeated follow-up examinations of these children.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17382108      PMCID: PMC2897232          DOI: 10.1016/j.jpeds.2006.12.013

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  44 in total

1.  Health effects of passive smoking. 9. Parental smoking and spirometric indices in children.

Authors:  D G Cook; D P Strachan; I M Carey
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

Review 2.  Pulmonary inflammation in the pathogenesis of bronchopulmonary dysplasia.

Authors:  P Groneck; C P Speer
Journal:  Pediatr Pulmonol Suppl       Date:  1997

Review 3.  Postnatal lung development and its impairment by glucocorticoids.

Authors:  S A Tschanz; P H Burri
Journal:  Pediatr Pulmonol Suppl       Date:  1997

4.  Reduced gas transfer at rest and during exercise in school-age survivors of bronchopulmonary dysplasia.

Authors:  S H Mitchell; W G Teague
Journal:  Am J Respir Crit Care Med       Date:  1998-05       Impact factor: 21.405

5.  Randomized placebo-controlled trial of a 42-Day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants.

Authors:  J M Kothadia; T M O'Shea; D Roberts; S T Auringer; R G Weaver; R G Dillard
Journal:  Pediatrics       Date:  1999-07       Impact factor: 7.124

Review 6.  Health effects of passive smoking-10: Summary of effects of parental smoking on the respiratory health of children and implications for research.

Authors:  D G Cook; D P Strachan
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

7.  Functional residual capacity and pulmonary mechanics in premature infants receiving a 12-day dexamethasone course.

Authors:  M Lee; P Diah; A N Krauss; P A Auld
Journal:  Am J Perinatol       Date:  1999       Impact factor: 1.862

8.  Evaluation of criteria for chronic lung disease in surviving very low birth weight infants. Newborn Lung Project.

Authors:  M Palta; M Sadek; J H Barnet; M Evans; M R Weinstein; G McGuinness; M E Peters; D Gabbert; D Fryback; P Farrell
Journal:  J Pediatr       Date:  1998-01       Impact factor: 4.406

9.  Early postnatal dexamethasone therapy may lessen lung inflammation in premature infants with respiratory distress syndrome on mechanical ventilation.

Authors:  J Y Wang; T F Yeh; Y J Lin; W Y Chen; C H Lin
Journal:  Pediatr Pulmonol       Date:  1997-03

10.  Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1993 through December 1994.

Authors:  D K Stevenson; L L Wright; J A Lemons; W Oh; S B Korones; L A Papile; C R Bauer; B J Stoll; J E Tyson; S Shankaran; A A Fanaroff; E F Donovan; R A Ehrenkranz; J Verter
Journal:  Am J Obstet Gynecol       Date:  1998-12       Impact factor: 8.661

View more
  9 in total

1.  Aerobic fitness and physical activity levels of children born prematurely following randomization to postnatal dexamethasone.

Authors:  Patricia A Nixon; Lisa K Washburn; Lanay M Mudd; Heather H Webb; T Michael O'Shea
Journal:  J Pediatr       Date:  2010-08-21       Impact factor: 4.406

Review 2.  Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.

Authors:  Lex W Doyle; Jeanie L Cheong; Susanne Hay; Brett J Manley; Henry L Halliday
Journal:  Cochrane Database Syst Rev       Date:  2021-11-11

Review 3.  Early (< 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.

Authors:  Lex W Doyle; Jeanie L Cheong; Susanne Hay; Brett J Manley; Henry L Halliday
Journal:  Cochrane Database Syst Rev       Date:  2021-10-21

4.  Predictors of wheezing in prematurely born children.

Authors:  Diane Holditch-Davis; Piper Merrill; Todd Schwartz; Mark Scher
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2008 May-Jun

Review 5.  Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.

Authors:  Lex W Doyle; Jeanie L Cheong; Richard A Ehrenkranz; Henry L Halliday
Journal:  Cochrane Database Syst Rev       Date:  2017-10-24

6.  Postnatal corticosteroids for bronchopulmonary dysplasia.

Authors:  Alan H Jobe
Journal:  Clin Perinatol       Date:  2009-03       Impact factor: 3.430

7.  Effect of dexamethasone exposure on the neonatal unit on the school age lung function of children born very prematurely.

Authors:  Christopher Harris; Siobhan Crichton; Sanja Zivanovic; Alan Lunt; Sandy Calvert; Neil Marlow; Janet L Peacock; Anne Greenough
Journal:  PLoS One       Date:  2018-07-09       Impact factor: 3.240

8.  Impaired exercise outcomes with significant bronchodilator responsiveness in children with prematurity-associated obstructive lung disease.

Authors:  Michael Cousins; Kylie Hart; E Mark Williams; Sailesh Kotecha
Journal:  Pediatr Pulmonol       Date:  2022-06-14

9.  Postnatal dexamethasone, respiratory and neurodevelopmental outcomes at two years in babies born extremely preterm.

Authors:  Gordon Qin; Jessica W Lo; Neil Marlow; Sandy A Calvert; Anne Greenough; Janet L Peacock
Journal:  PLoS One       Date:  2017-07-19       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.